Document is current
Any future updates will be listed below
-
Authors
Yang, Seungwon https://orcid.org/0000-0002-8970-7373
Cui, Yan-Hong https://orcid.org/0000-0002-4169-6521
Li, Haixia
Wei, Jiangbo https://orcid.org/0000-0003-2691-6490
Park, Gayoung
Sun, Ming
Verghese, Michelle
Wilkinson, Emma
Nam, Teresa
Lungstrom, Linnea Louise https://orcid.org/0000-0002-2989-674X
Cui, Xiaolong
Ryu, Tae Young
Chen, Jing
Bissonnette, Marc https://orcid.org/0000-0001-8420-4294
He, Chuan https://orcid.org/0000-0003-4319-7424
He, Yu-Ying https://orcid.org/0000-0002-2665-7962
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (ES031693, ES024373)
U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (ES027792)
U.S. Department of Health & Human Services | NIH | National Cancer Institute (CA014599)
- License Information
-
More Information
Article History
Received: 16 December 2024
Accepted: 30 September 2025
First Online: 12 November 2025
Competing interests
: C.H. is a scientific founder, a member of the scientific advisory board and equity holder of Aferna Bio and Ellis Bio, a scientific cofounder and equity holder of Accent Therapeutics, and a member of the scientific advisory board of Rona Therapeutics and Element Biosciences. The other authors declare no competing interests.
